| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 1987 (ast)
- наукова стаття, опублікована у вересні 1987 (uk)
- مقالة علمية نشرت في سبتمبر 1987 (ar)
- scientific article published on September 1987 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| cites work
| |
| cites work
| - Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.
- Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency
- Cefixime disk susceptibility test criteria
- In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites
- In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic
- In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins
- In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae
- In-vitro activity of Ro-15-8074, a new oral cephalosporin
- Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
- In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
|
| rdfs:label
| - Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests (en)
- Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests (ast)
- Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (nl)
|
| skos:prefLabel
| - Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests (en)
- Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests (ast)
- Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (nl)
|
| name
| - Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests (en)
- Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests (ast)
- Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (nl)
|
| author
| |
| author
| |
| title
| |
| title
| - Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1128/JCM.25.9.1796-1799.1987
|
| PMCID
| |
| PMCID
| |
| is about
of | |
| is cites work
of | - MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin
- Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin
- Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
- MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin
- Cefetamet pivoxil: bacteriostatic and bactericidal activity of the free acid against 355 gram-negative rods
- Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam
- Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem
- Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin
- Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)
- Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin
- Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.
- Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates
- Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)